Hospital management company Universal Health Services (NYSE: UHS) met Wall Street’s revenue expectations in Q3 2026, with sales up 5.3% year on year to $4.73 billion. Its non-GAAP profit of $5.22 per share was 1.3% above analysts’ consensus estimates.

Is now the time to buy UHS? Find out in our full research report (it’s free for active Edge members).

StockStory’s take

Universal Health Services’ third quarter results were met with a negative market reaction, despite the company meeting Wall Street’s revenue expectations and modestly exceeding non-GAAP profit estimates. Management cited sequential improvement in acute care demand and increased behavioral health volumes, alongside continued moderation in labor costs. However, CEO Marc Miller acknowledged that a slower-than-expected ramp-up at new hospitals and softness in surgical trends weighed on overall performance. CFO Steve Filton noted, “The shortfall primarily reflected a slower than expected ramp-up at our de novo hospitals and softer than expected surgical trends,” emphasizing the impact of shifts in service mix and ongoing integration efforts.

Looking forward, Universal Health Services’ guidance is shaped by expectations for continued growth in acute and behavioral health volumes, but management cautioned about headwinds from regulatory changes and facility ramp-up timing. The integration of the Talkspace acquisition is central to expanding outpatient mental health offerings, with management expecting long-term synergies from cross-referrals and technology enhancements. CFO Steve Filton explained, “The vast majority of synergies are revenue synergies, and the opportunity that combining the lower acuity population, patient population that Talkspace has and the higher acuity patient population that UHS has really creates this robust continuum of care.” Management reiterated that upcoming Medicaid supplemental funding cuts and changes in exchange enrollment will also influence 2027 results.

Key insights from management’s remarks

Management attributed the quarter’s performance to improved acute care volumes and steady behavioral health demand, but noted margin pressure from service mix shifts and slower new facility ramp-ups.

• Acute care volume growth: Same-facility acute care admissions increased, with demand strongest in emergency and medical service lines such as cardiology and neurology. Geographic volume gains were broad-based, but a heavier mix of medical (versus surgical) cases pressured pricing trends and margins.
• Surgical mix headwinds: The company saw a continued shift of surgical procedures, particularly in gastrointestinal and orthopedics, from hospitals to outpatient and physician office settings. This trend accelerated, reducing procedural volumes and contributing to lower revenue per admission.
• Behavioral health momentum: Behavioral health volumes improved modestly as staffing constraints eased and outpatient offerings expanded. Nevertheless, operating results were held back by ongoing losses at the Laurel Ridge facility, which remains in recertification, and startup losses from new projects.
• Talkspace integration progress: The acquisition of Talkspace, a virtual behavioral health provider, was completed and integration began, with early focus on technology deployment, referral flows, and new outpatient program offerings. Management plans to elaborate on expected synergies in future guidance updates.
• Labor and expense control: Labor costs moderated in both segments, with reductions in contract labor and wage inflation trending toward pre-pandemic levels. Expense discipline extended to supply costs, helping offset some margin pressures from payer and service mix changes.

Drivers of future performance

Universal Health Services’ outlook reflects cautious optimism, with future performance hinging on outpatient growth, facility maturation, and regulatory developments.

• Facility ramp-up and recertification: Management emphasized that the pace of operating improvement at new hospitals, particularly Palm Beach Gardens and Cedar Hill, and the recertification of Laurel Ridge, will be major determinants of margin recovery and earnings growth through 2027. Delays in these projects have already impacted results, and their progression will be closely monitored.
• Behavioral health and outpatient expansion: The integration of Talkspace and ongoing investment in outpatient offerings—such as intensive outpatient programs and virtual care—are expected to drive long-term growth, diversify payer mix, and reduce reliance on Medicaid. Management aims to leverage cross-referrals between inpatient and outpatient channels to capture more patient volume across the continuum of care.
• Regulatory and payer mix headwinds: Anticipated reductions in Medicaid supplemental funding, potential impacts from Medicaid work requirements, and continued declines in exchange enrollment are expected to weigh on revenue in 2027 and beyond. Management estimated a $175–$200 million headwind from supplemental funding cuts and highlighted ongoing monitoring of state-specific regulatory changes.

Catalysts in upcoming quarters

In the coming quarters, the StockStory team will be watching (1) the pace of patient volume and margin recovery at new and recently expanded acute care facilities, (2) operational progress and recertification at Laurel Ridge Treatment Center, and (3) the effectiveness of the Talkspace integration in accelerating outpatient behavioral health growth. Additional focus will be placed on managing regulatory headwinds and the evolution of payer mix.

Universal Health Services currently trades at $172.49, down from $177.33 just before the earnings. Is there an opportunity in the stock? See for yourself in our full research report (it’s free).

Now could be the perfect time to invest in these stocks

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.